Carl Zeiss Meditec AG
XETRA:AFX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
54.65
121.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG
Long-Term Debt
Carl Zeiss Meditec AG
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Long-Term Debt
€217m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
34%
|
|
|
Stratec SE
XETRA:SBS
|
Long-Term Debt
€93.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
33%
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Long-Term Debt
€42.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
23%
|
CAGR 10-Years
12%
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Long-Term Debt
€14.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
226%
|
CAGR 10-Years
N/A
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Long-Term Debt
€254.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
4%
|
|
|
Sartorius AG
XETRA:SRT
|
Long-Term Debt
€4.4B
|
CAGR 3-Years
36%
|
CAGR 5-Years
37%
|
CAGR 10-Years
26%
|
|
Carl Zeiss Meditec AG
Glance View
Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 3,531 full-time employees. The company went IPO on 2000-03-20. The company offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The firm has various production sites in Europe, the United States and Asia.
See Also
What is Carl Zeiss Meditec AG's Long-Term Debt?
Long-Term Debt
217m
EUR
Based on the financial report for Jun 30, 2024, Carl Zeiss Meditec AG's Long-Term Debt amounts to 217m EUR.
What is Carl Zeiss Meditec AG's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
34%
Over the last year, the Long-Term Debt growth was 9%. The average annual Long-Term Debt growth rates for Carl Zeiss Meditec AG have been 4% over the past three years , 6% over the past five years , and 34% over the past ten years .
You don't have any saved screeners yet
